Phreesia, Inc. (NYSE:PHR) Given Consensus Recommendation of "Hold" by Brokerages

Key Points

• Phreesia has a consensus “Hold” rating from 18 analysts: nine recommend holding, eight recommend buying, and one recommends selling. The average 12-month price target is $14.00, above the stock’s reported $10.97 price.
• Institutional investors own 92.1% of Phreesia’s shares, with several funds increasing their positions during the first quarter, including Royal Bank of Canada and AQR Capital Management.
• Phreesia’s latest quarterly revenue rose 10.4% year over year to $129.46 million, slightly beating estimates, but adjusted EPS of $0.03 missed the $0.09 consensus forecast.

Phreesia, Inc. (NYSE:PHR - Get Free Report) has earned a consensus rating of "Hold" from the eighteen research firms that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and eight have assigned a buy rating to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $14.00.

A number of analysts recently weighed in on PHR shares. Canaccord Genuity Group reiterated a "buy" rating and issued a $16.00 price target on shares of Phreesia in a research report on Thursday, September 3rd. Royal Bank Of Canada restated an "outperform" rating and set a $19.00 price objective on shares of Phreesia in a report on Thursday, September 3rd. Wells Fargo & Company upped their target price on shares of Phreesia from $9.00 to $10.00 and gave the company an "equal weight" rating in a research note on Thursday. Truist Financial increased their target price on shares of Phreesia from $11.00 to $12.00 and gave the stock a "hold" rating in a report on Thursday, May 28th. Finally, Needham & Company LLC reissued a "buy" rating and set a $14.00 price target on shares of Phreesia in a research report on Monday, August 31st.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Royal Bank of Canada raised its position in shares of Phreesia by 208.8% during the first quarter. Royal Bank of Canada now owns 24,119 shares of the company's stock worth $617,000 after purchasing an additional 16,309 shares during the period. AQR Capital Management LLC raised its stake in shares of Phreesia by 471.2% in the 1st quarter. AQR Capital Management LLC now owns 160,032 shares of the company's stock valued at $4,090,000 after purchasing an additional 132,015 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Phreesia by 3.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 62,557 shares of the company's stock worth $1,599,000 after buying an additional 2,158 shares during the period. NewEdge Advisors LLC grew its holdings in shares of Phreesia by 262.7% during the first quarter. NewEdge Advisors LLC now owns 15,437 shares of the company's stock worth $395,000 after buying an additional 11,181 shares in the last quarter. Finally, Goldman Sachs Group Inc. grew its stake in shares of Phreesia by 0.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 600,012 shares of the company's stock worth $15,336,000 after acquiring an additional 2,402 shares in the last quarter. 92.10% of the stock is currently owned by institutional investors.

Phreesia Trading Up 0.3%

NYSE:PHR opened at $10.97 on Tuesday. Phreesia has a 1-year low of $7.77 and a 1-year high of $30.43. The business's 50-day moving average price is $11.26 and its two-hundred day moving average price is $10.46. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $680.91 million, a price-to-earnings ratio of 64.53 and a beta of 0.86.

Phreesia (NYSE:PHR - Get Free Report) last posted its earnings results on Wednesday, September 2nd. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.06). The company had revenue of $129.46 million for the quarter, compared to analyst estimates of $129.06 million. Phreesia had a return on equity of 5.22% and a net margin of 2.06%.Phreesia's quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.01 earnings per share. On average, equities analysts expect that Phreesia will post 0.38 earnings per share for the current year.

Phreesia Company Profile

Phreesia, Inc NYSE: PHR is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company's cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.